Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 5/20 | 0.69 |
| ▸ | CYP2C19 | P33261 | 4/20 | 0.69 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.69 |
| ▸ | HPGD | P15428 | 2/20 | 0.55 |
| ▸ | HTT | P42858 | 2/20 | 0.55 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.53 |
| ▸ | NPC1 | O15118 | 1/20 | 0.50 |
| ▸ | RAB9A | P51151 | 1/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.49 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.47 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.47 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.47 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.47 |
| ▸ | ACP3 | P15309 | 1/20 | 0.46 |
| ▸ | POLB | P06746 | 1/20 | 0.45 |
| ▸ | MEN1 | O00255 | 1/20 | 0.45 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.45 |
| ▸ | IFNAR1 | P17181 | 1/20 | 0.43 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.43 |
| ▸ | ADRA2B | P18089 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9456743 | 0.82 | CYP1A2 (1.00) | CYP1A2CYP2C19CYP2C9HPGDHTT | |
| SCHEMBL7520769 | 0.79 | CYP1A2 (0.77) | CYP1A2CYP2C19CYP2C9HPGDHTT | |
| SCHEMBL14492356 | 0.79 | CYP1A2 (0.53) | CYP1A2CYP2C19CYP2C9HPGDHTT | |
| SCHEMBL22342261 | 0.79 | CYP1A2 (0.44) | CYP1A2CYP2C19CYP2C9CYP2D6ALDH1A1 | |
| SCHEMBL271106 | 0.78 | CYP1A2 (0.69) | CYP1A2CYP2C19CYP2C9HPGDHTT | |
| SCHEMBL8813943 | 0.78 | CYP1A2 (0.69) | CYP1A2CYP2C19CYP2C9HPGDHTT | |
| SCHEMBL3083039 | 0.78 | MAPT (0.39) | CYP1A2CYP2C19CYP2C9HTTCYP2D6 | |
| SCHEMBL23060513 | 0.77 | CYP1A2 (0.49) | CYP1A2CYP2C19CYP2C9HPGDHTT | |
| SCHEMBL13209683 | 0.76 | POLB (0.46) | CYP1A2CYP2C19CYP2C9HPGDNPC1 | |
| SCHEMBL18410082 | 0.76 | CYP1A2 (0.50) | CYP1A2CYP2C19CYP2C9HPGDCYP2D6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 58 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4081597-A1 | UV RESISTANT SURFACING MATERIALS FOR COMPOSITE PARTS | Cytec Industries, Inc. (US) | 2022-11-02 | — | — | EP | claimed |
| US-4818749-A | Carboxyalkyl dipeptides and medical use thereof in treating hypertension and congestive heart failure | SCHERING CORPORATION (US) | 1989-04-04 | — | — | US | claimed |
| US-12435237-B2 | UV resistant surfacing materials for composite parts | CYTEC INDUSTRIES INC. (US) | 2025-10-07 | — | — | US | disclosed |
| EP-4081597-B1 | UV RESISTANT SURFACING MATERIALS FOR COMPOSITE PARTS | CYTEC IND INC (US) | 2023-10-11 | — | — | EP | disclosed |
| US-20230212204-A1 | REAGENTS AND THEIR USE FOR MODULAR ENANTIODIVERGENT SYNTHESIS OF C-P BONDS | THE SCRIPPS RESEARCH INSTITUTE | 2023-07-06 | — | — | US | disclosed |
| US-20230151138-A1 | STEREOISOMER OF EPOXY COMPOUND, CURABLE COMPOSITION CONTAINING THE SAME, AND CURED PRODUCT OBTAINED BY CURING CURABLE COMPOSITION | ENEOS CORPORATION (JP) | 2023-05-18 | — | — | US | disclosed |
| US-20230091593-A1 | UV RESISTANT SURFACING MATERIALS FOR COMPOSITE PARTS | CYTEC INDUSTRIES INC. | 2023-03-23 | — | — | US | disclosed |
| EP-4081597-A1 | UV RESISTANT SURFACING MATERIALS FOR COMPOSITE PARTS | Cytec Industries, Inc. (US) | 2022-11-02 | — | — | EP | disclosed |
| CN-115279768-A | Stereoisomer of epoxy compound, curable composition containing same, and cured product obtained by curing curable composition | 引能仕株式会社 | 2022-11-01 | — | — | CN | disclosed |
| WO-2021112062-A1 | ALICYCLIC ACRYLATE COMPOUND, ALICYCLIC EPOXY ACRYLATE COMPOUND, CURABLE COMPOSITION, AND CURED ARTICLE | ＥＮＥＯＳ株式会社 | 2021-06-10 | — | — | WO | disclosed |
| WO-2021053993-A1 | ACID GENERATOR AND CURABLE COMPOSITION CONTAINING SAME | サンアプロ株式会社 | 2021-03-25 | — | — | WO | disclosed |
| US-20040235816-A1 | Azetidine derivatives, their preparation and medicaments containing them | AVENTIS PHARMA S.A. (FR) | 2004-11-25 | — | — | US | disclosed |
| US-20030162808-A1 | Acetindine derivatives, their preparation and medicaments containing them | AVENTIS PHARMA S.A. (FR) | 2003-08-28 | — | — | US | disclosed |
| EP-1112251-B1 | AZETIDINE DERIVATIVES, PREPARATION AND MEDICINES CONTAINING THEM | AVENTIS PHARMA SA (FR) | 2003-05-07 | — | — | EP | disclosed |
| US-6518264-B2 | For treatment/prevention of psychoses, other brain disorders, and cardiovascular disorders | AVENTIS PHARMA S.A. (FR) | 2003-02-11 | — | — | US | disclosed |
| US-20020035102-A1 | Azetidine derivatives, their preparation and medicaments containing them | AVENTIS PHARMA S.A. (FR) | 2002-03-21 | — | — | US | disclosed |
| EP-1112251-A1 | AZETIDINE DERIVATIVES, PREPARATION AND MEDICINES CONTAINING THEM | Aventis Pharma S.A. (FR) | 2001-07-04 | — | — | EP | disclosed |
| WO-2000015609-A1 | AZETIDINE DERIVATIVES, PREPARATION AND MEDICINES CONTAINING THEM | AVENTIS PHARMA S.A. (FR) | 2000-03-23 | — | — | WO | disclosed |
| US-4818749-A | Carboxyalkyl dipeptides and medical use thereof in treating hypertension and congestive heart failure | SCHERING CORPORATION (US) | 1989-04-04 | — | — | US | disclosed |
| US-4808573-A | ANGIOTENSIN CONVERTING ENZYME INHIBITORS | SCHERING CORPORATION (US) | 1989-02-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040235816-A1 | Azetidine derivatives, their preparation and medicaments containing them | AZI2, ADRA2A, ADRA2C | CYP1A2 26/4885CYP2C19 12/4885CYP2C9 31/4885 |
| US-20230151138-A1 | STEREOISOMER OF EPOXY COMPOUND, CURABLE COMPOSITION CONTAINING THE SAME, AND CURED PRODUCT OBTAINED BY CURING CURABLE COMPOSITION | PTGER1, SEM1, REV1 | CYP1A2 684/4885CYP2C19 839/4885CYP2C9 1296/4885 |
| US-20230212204-A1 | REAGENTS AND THEIR USE FOR MODULAR ENANTIODIVERGENT SYNTHESIS OF C-P BONDS | PNKP, POLL, RNGTT | CYP1A2 3705/4885CYP2C19 2782/4885CYP2C9 1768/4885 |
| US-20020035102-A1 | Azetidine derivatives, their preparation and medicaments containing them | CYP11B2, AZI2, CYP2C19 | CYP1A2 8/4885CYP2C19 3/4885CYP2C9 10/4885 |
| US-20030162808-A1 | Acetindine derivatives, their preparation and medicaments containing them | ADRA1D, ADRB2, AZI2 | CYP1A2 14/4885CYP2C19 17/4885CYP2C9 44/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.